About Circle Cardiovascular Imaging
Circle Cardiovascular Imaging (Circle CVI) is a Canadian-based medical imaging software company founded in 2007 that has become a globally recognized leader in cardiovascular imaging analysis. The company develops innovative AI-powered software solutions designed to enhance cardiovascular imaging analysis and improve patient care across cardiac and neurological applications. Circle's flagship platform, cvi42, provides comprehensive tools for cardiac MR, cardiac CT, vascular CT, interventional planning, and electrophysiology, serving as an all-encompassing cardiac imaging solution. The platform features automated workflows powered by AI trained on large datasets and various pathological patterns, enabling accurate diagnosis, improved patient throughput, and enhanced reproducibility. In 2024, Circle launched its next generation of products centered on accessibility, interoperability, and efficiency. The company also offers StrokeSENS, an AI-based solution for early identification of acute stroke that aids front-line physicians in timely patient management decisions. With over 600 installations worldwide across more than 100 countries, Circle serves leading healthcare institutions globally, including top hospitals that rely on its technology for both clinical and research purposes. The company maintains strong partnerships with major medical imaging OEMs including GE Healthcare and Siemens Healthineers, offering integrated deployment options on their workstation platforms. Circle's solutions seamlessly integrate with existing clinical workflows and systems, featuring streamlined reporting capabilities that reduce clerical workload and improve patient outcomes. The company has earned industry-leading customer satisfaction scores and maintains a reputation for exceptional customer service and continuous innovation in the cardiovascular imaging field.
Mission & Story
Mission
We Enhance Healthcare Outcomes by Unlocking Data Insights from Medical Imaging Procedures to Empower Efficient and Reliable Decision-Making across the Medical Landscape
Founding Story
Circle Cardiovascular Imaging was established in 2007 with the aim of developing innovative software solutions to enhance cardiovascular imaging analysis and improve patient care. Since its inception, the company has grown to become a globally recognized leader in the field, driven by an unrelenting commitment to continually offer better solutions for healthcare providers that improve healthcare outcomes.
Clinical Focus
Medical conditions and clinical areas addressed by Circle Cardiovascular Imaging.
Who It Serves
Milestones & Awards
Recent Milestones
2024 marked the launch of next generation of products centered around accessibility, interoperability, and efficiency. cvi42 version 6.4 released.
Awards & Recognition
Market-leading expert in cardiovascular imaging, industry-leading customer satisfaction scores
Key Partnerships
Company Details
- Founded
- 2007
- Headquarters
- Canada
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.